TScan Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of TCRX for the last quarter is 536.00 k USD, and it's 5.30% lower compared to the previous quarter. The net income of Q2 24 is -31.66 M USD.